Zebic DS, Tjokrowidjaja A, Francis KE, Friedlander M, et al. Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer. Br J Cancer 2023 Dec 14. doi: 10.1038/s41416-023-02528.
PMID: 38097739